Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

HUMANA INC : Regulation FD Disclosure (form 8-K)

12/01/2021 | 07:34am EST
Item 7.01  Regulation FD Disclosure.
Members of Humana Inc.'s (the "Company") senior management team are scheduled to
meet with investors at various times between December 1, 2021 and December 31,
2021. During the meetings, the Company intends to reaffirm its guidance of
approximately $23.67 in diluted earnings per common share ("EPS"), or
approximately $20.50 in adjusted earnings per common share ("Adjusted EPS"), in
each case for the year ending December 31, 2021 ("FY 2021"). This guidance is
consistent with the guidance issued in Humana's press release dated November 3,
2021. The date and time of presentations to investors are available via the
Investor Relations calendar of events on Humana's website at humana.com.

The Company has included Adjusted EPS in this current report, a financial
measure that is not in accordance with Generally Accepted Accounting Principles
("GAAP"). Management believes that this measure, when presented in conjunction
with the comparable measure of GAAP EPS, is useful to both management and its
investors in analyzing the Company's ongoing business and operating performance.
Consequently, management uses Adjusted EPS as an indicator of the Company's
business performance, as well as for operational planning and decision making
purposes. Adjusted EPS should be considered in addition to, but not as a
substitute for, or superior to, GAAP EPS. A reconciliation of GAAP EPS to
Adjusted EPS follows:

                    Diluted earnings per common share                             FY 2021 Guidance
GAAP                                                                                              ~$23.67
Amortization of identifiable intangibles                                                            ~0.39
Gain on Kindred at Home equity method investment                                                   (8.73)

Put/call valuation adjustments associated with company's non-consolidating

minority interest investments
Transaction and integration costs associated with the Kindred at Home                                0.61


Change in fair market value of publicly-traded equity securities                                     1.18
Adjusted (non-GAAP) - FY 2021 projected                                                           ~$20.50


© Edgar Online, source Glimpses

All news about HUMANA INC.
01/25Go365« by Humana Announces Winners of Fourth Annual National Step Challenge, Resulting ..
01/21CenterWell Senior Primary Care Announces Expansion Plan for 2022 - Phoenix, Dallas, Ft...
01/20CenterWell Senior Primary Care Announces Expansion Plan for 2022 – Phoenix, Dalla..
01/14Humana Names Dr. Andrew Agwunobi President of Company's Home Solutions Business
01/14Humana Names Dr. Andrew Agwunobi as President of Company’s Home Solutions Business
01/13Humana Inc. to Release Fourth Quarter 2021 Results on February 2, 2022
01/12Humana Enters Agreements To Repurshare $1 Billion Common Shares
01/12Humana Sets $1 Billion Accelerated Stock Buyback
01/12HUMANA INC : Entry into a Material Definitive Agreement, Financial Statements and Exhibits..
01/10Humana on Track for Largest Percent Increase in Over a Year -- Data Talk
More news
Analyst Recommendations on HUMANA INC.
More recommendations